Terms: = Skin cancer AND ECT2L, 345930, C6orf91, Q008S8, LFDH, dJ509I19_3, dJ509I19_2, ENSG00000203734 AND Staging
1736 results:
1. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
Fang Q; Yuan J; Zhang X; Dai L; Luo R
BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
[TBL] [Abstract] [Full Text] [Related]
2. Molecular Markers in Melanoma Progression: A Study on the Expression of miRNA Gene Subtypes in Tumoral vs. Benign Nevi.
Prodan M; Costescu S; Elagez A; Laitin SMD; Bloanca V; Crainiceanu Z; Seclaman E; Toma AO; Fericean RM; Puenea G; Cozma GV
Curr Oncol; 2024 May; 31(5):2881-2894. PubMed ID: 38785501
[TBL] [Abstract] [Full Text] [Related]
3. A comparison of port-site infiltration with bupivacaine alone vs. bupivacaine plus dexemedetomidine after diagnostic staging laparoscopy.
Qureshi RS; Alam T; Saleem H
J Pak Med Assoc; 2024 May; 74(5):857-861. PubMed ID: 38783430
[TBL] [Abstract] [Full Text] [Related]
4. Observation of lymphadenopathy, systemic symptoms, and treatment in suspected indolent cutaneous B-cell lymphomas.
Puccio J; Huang Y; Viveiros MD; Reneau JC; Chung C; Spaccarelli N; Dulmage B
Arch Dermatol Res; 2024 May; 316(5):199. PubMed ID: 38775835
[TBL] [Abstract] [Full Text] [Related]
5. Influence of Anatomic Locations of T1b Melanomas and Patient Age on Outcomes.
Huang MY; Chen A; Quarshie C; Masson R; Barajas G; Kim G; DeClerck B; Swanson MS; In GK; Kokot N; Pickering TA; Hu JC
J Drugs Dermatol; 2024 May; 23(5):306-310. PubMed ID: 38709694
[TBL] [Abstract] [Full Text] [Related]
6. Uveal melanoma incidence and survival analysis in Portugal between 2013 and 2022.
Geada S; Machado T; Teixeira T; Simões PC; Oliveiros B; da Luz Cachulo M; Fonseca C; Proença R
Cancer Epidemiol; 2024 Jun; 90():102575. PubMed ID: 38663175
[TBL] [Abstract] [Full Text] [Related]
7. [Construction and Validation of Prediction Models of Risk Factors for Early Death in Patients With Metastatic Melanoma].
Li S; Li J; Yang Q; Yin C; Liu B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):367-374. PubMed ID: 38645854
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic nomograms for predicting long-term overall survival in spindle cell melanoma: a population-based study.
Lau WC; Huang L; Zheng X; Ming WK; Leong NC; Tak Wong Y; Yin Z; Yu H; Lyu J; Deng L
Front Endocrinol (Lausanne); 2024; 15():1260966. PubMed ID: 38572477
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
10. Additional Findings of 18 F-AIF-FAPI-42 PET/CT in a Patient With Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma : Comparisons With 18 F-FDG PET/CT.
Liu G; Li Y; Du B; Cui Y; Li X
Clin Nucl Med; 2024 May; 49(5):e199-e201. PubMed ID: 38465934
[TBL] [Abstract] [Full Text] [Related]
11. Risk of progression of early-stage mycosis fungoides, 10-year experience.
Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
[TBL] [Abstract] [Full Text] [Related]
12. Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Kirkwood JM; Vecchio MD; Weber J; Hoeller C; Grob JJ; Mohr P; Loquai C; Dutriaux C; Chiarion-Sileni V; Mackiewicz J; Rutkowski P; Arenberger P; Quereux G; Meniawy TM; Ascierto PA; Menzies AM; Durani P; Lobo M; Campigotto F; Gastman B; Long GV
Future Oncol; 2024 May; 20(15):959-968. PubMed ID: 38390818
[TBL] [Abstract] [Full Text] [Related]
13. Recent treatment and prognosis in 643 patients with extramammary Paget's disease.
Hatta N; Ogata D; Asai J; Maekawa T; Ito T; Takenouchi T; Kiniwa Y; Miyashita A; Miyagawa T; Muto I; Yamamoto Y; Nagano T; Kiyohara Y; Nakano E; Ohe S; Yamaguchi B; Fukuyama M; Matsuya T; Tsutsumida A; Namikawa K; Yamazaki N
Exp Dermatol; 2024 Feb; 33(2):e15030. PubMed ID: 38375900
[TBL] [Abstract] [Full Text] [Related]
14. Impact of extra-nodal extension and AJCC lymph node staging in predicting recurrence following lymphadenectomy in patients with melanoma.
Downey J; Hamm J; Baliski C
Am J Surg; 2024 May; 231():120-124. PubMed ID: 38320886
[TBL] [Abstract] [Full Text] [Related]
15. Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.
Varey AHR; Li I; El Sharouni MA; Simon J; Dedeilia A; Ch'ng S; Saw RPM; Spillane AJ; Shannon KF; Pennington TE; Rtshiladze M; Stretch JR; Nieweg OE; van Akkooi A; Sullivan RJ; Boland GM; Gershenwald JE; van Diest PJ; Scolyer RA; Long GV; Thompson JF; Lo SN
J Clin Oncol; 2024 Apr; 42(10):1169-1180. PubMed ID: 38315961
[TBL] [Abstract] [Full Text] [Related]
16. Actinic keratoses and squamous cell carcinoma limited to photo-exposed skin in vitiligo vulgaris in pigmented skin type.
Sirka CS; Sethy M; Rout AN
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38286583
[TBL] [Abstract] [Full Text] [Related]
17. Survival impact of post-operative immunotherapy in resected stage III cutaneous melanomas in the checkpoint era.
Hagopian G; Jiang X; Grant C; Brazel D; Kumar P; Yamamoto M; Jakowatz J; Chow W; Tran T; Shen W; Moyers J
ESMO Open; 2024 Feb; 9(2):102193. PubMed ID: 38271786
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Value of BAP1 Protein Expression in Uveal Melanoma.
Kennedy S; Owens S; Ivers L; Hegarty C; O'Neill V; Berenguer-Pina JJ; Horgan N; Crown J; Walsh N
Am J Surg Pathol; 2024 Mar; 48(3):329-336. PubMed ID: 38238977
[TBL] [Abstract] [Full Text] [Related]
19. Simultaneous melanomas in the setting of multiple primary melanomas.
Kostaki M; Plaka M; Befon A; Dessinioti C; Kypraiou K; Chardalia V; Christofidou E; Polydorou D; Stratigos A
Melanoma Res; 2024 Apr; 34(2):198-201. PubMed ID: 38224405
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic value of [ 68 Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
Manafi-Farid R; Mahini M; Mirshahvalad SA; Fallahi B; Fard-Esfahani A; Emami-Ardekani A; Eftekhari M; Mousavi SA; Beiki D
Nucl Med Commun; 2024 Mar; 45(3):221-228. PubMed ID: 38214076
[TBL] [Abstract] [Full Text] [Related]
[Next]
